Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology/Infectious Diseases | Dermatology/Plastic Surgery
Disease Category: Hereditary Angioedema
Trial Information
Human C1 Esterase Inhibitor (C1-INH) in Subjects with congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks.
Condition: Hereditary Angioedema (HAE)
Study Description: The purpose of this study is
to show that C1-INH concentrate ( an investigational product )
shortens the time to onset of relief of symptoms of abdominal or
facial HAE attacks compared to placebo.
Patient Inclusion Criteria
You may be able to participate in this study if you:
- Have a diagnosis of hereditary C1-INH deficiency
- Have a documented history of facial or abdominal attacks
- Are 6 years of age or older
Patient Exclusion Criteria
You may not participate in this study if you:
- Have been treated with any C1-INH product within the previous 7
days
- Have been treated with any investigational drug within the last
30 days
- Are being treated with an ACE inhibitor
Yolanda Gordon-Scott MA, CRC, Marketing Coordinator/Patient Recruiter
Allergy/Immunology Research Center of North Texas
7777 Forest Lane Suite B-332
Dallas
Dallas, TX 75230
Phone: 972-566-7471
Fax: 972-566-6831
EMail: studyrecruiter@yahoo.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
